Participations à des congrès et colloques internationaux (65)
  1. 11. Rosiere, R., Bischof, R., Chraibi, S., Hennia, I., Meeusen, E., Amighi, K., & Wauthoz, N. (2020). Pharmacokinetic and Preliminary Toxicity Investigation of an Innovative Controlled-Release Cisplatin Dry Powder Inhalation Formulation in Sheep. Poster présenté à la conférence Respiratory Drug Delivery 2020 (26/04/2020-30/06/2020: Digital).
  2. 12. Chraibi, S., Spires, J. J., Amighi, K., & Wauthoz, N. (2018). In silico Prediction of Pharmacokinetic Parameters after Cisplatin Intravenous and Endotracheal Administration Using GastroPlus TM Software. Poster présenté à la conférence Drug Delivery to the lung (28: 12-14th December 2018: Edinburg).
  3. 13. Wauthoz, N. (2018). Formulation strategies of dry powders related to the lung diseases. Paper session presented at SimInhale COST action MP1404 Summer School 2018 and 5th Workshop on Pulmonary Drug Delivery (3-6th September 2018: Dublin).
  4. 14. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2017). Impact of the capsule type on the aerodynamic performances of a fluticasone-based dry powder under optimal and suboptimal inhalation airflows. Poster présenté à la conférence Drug Delivery to the lungs (28: 2017-12-06-08: Edimbourg).
  5. 15. Rosiere, R., Chraibi, S., Albasry, S., Vermeech, M., Amighi, K., & Wauthoz, N. (2017). Development of paclitaxel nanocrystal-based dry powder formulations for targeted therapy of lung tumours by inhalation. Poster présenté à la conférence Drug Delivery to the lungs (DDL) (28: 2017-12-06-08: Edimbourg).
  6. 16. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2017). A Comparative Evaluation of the Aerosolization Performances of Marketed Fluticasone Multi-Unit and Single-Unit Dry Powder Inhalers (DPIs): The Effects of Product Use Life, Suboptimal Airflow and a Hot/Humid Environment. Poster présenté à la conférence American Association of Pharmaceutical Scientists (AAPS) (2017: 2017-11-12-15: San Diego).
  7. 17. Salade, L., Wauthoz, N., De Vriese, C., Amighi, K., & Goole, J. (2017). Development of a Dry-Powder Formulation with Ghrelin-loaded Liposomes for Nose-to-Brain Delivery. Poster présenté à la conférence 2nd European Conference on Pharmaceutics, Novel Dosage Forms & Innovative Technologies (3 April to 4 April 2017: Krakow, Poland).
  8. 18. Rosiere, R., Van Woensel, M., Mathieu, V., Mathivet, T., Amighi, K., & Wauthoz, N. (2016). New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy. Paper session presented at Drug Delivery to the lung (27th world meeting: 7-9/12/2016: Edinburg (UK)).
  9. 19. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2016). Impact of different capsules for dry powder inhalers on the aerodynamic performances of formoterol-based binary and ternary blends. Poster présenté à la conférence Drug Delivery to the lung (27th world meeting: 7-9/12/2016: Edinburg (UK)).
  10. 20. Levet, V., Rosiere, R., Amighi, K., & Wauthoz, N. (2016). Local and systemic pharmacokinetic evaluation of immediate-release and controlled-release cisplatin dry powders for inhalation against lung cancer. In Journal of Pulmonary Delivery - Abstract book of Drug Delivery to the Lungs conference 27 Journal of Aerosol Medicine and Pulm.
  11. 21. Levet, V., Rosiere, R., Amighi, K., & Wauthoz, N. (2016). Local and systemic pharmacokinetic evaluation of immediate-release and controlled-release cisplatin dry powders for inhalation against lung cancer. Poster présenté à la conférence Drug delivery to the lungs (27: December 6-9th 2016: Edinburgh, Scotland).
  12. 22. Wauthoz, N., Hennia, I., Ecenarro, S., & Amighi, K. (2016). Influence of flow rate and uasage in drastic condition on the aerodynamic performance of a formoterol dry powder formulation using different kinds of capsules for inhalation. Poster présenté à la conférence AAPS (2016: 13-17/11/2016: Denver (USA)).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>